Telcare this week got the green light to market its cellphone-enabled blood glucose meter in the European Union, the Bethesda, Md.-based company announced.
The device, the first FDA-cleared mHealth glucose meter, connects patients and caregivers in real time with actionable data, according to a press release.
Telcare’s blood glucose meter uses cellular-enabled mHealth tools to securely capture, store and share real-time clinical data, enabling care teams to access crucial information that can be used to identify at-risk individuals, make targeted and informed interventions and prevent complications, the company claims.
"We are excited to expand our reach of innovative, comprehensive diabetes management solutions to the European Union," CEO and vice-chairman Dr. Jonathan Javitt said in a press statement. "Our mobile platform unlocks the power of clinical data and creates multiple engagement points amongst those involved in an individual’s care to help minimize complications and improve health outcomes."
More than 360 million people are currently living with diabetes, with this number expected to escalate to 552 million by 2030, Telcare noted. Although the complications of diabetes can be prevented through daily monitoring and control of blood sugar, the World Health Organization estimates that 8,700 people are still dying daily from the disease.
Telcare said it recently partnered with Qualcomm Life’s 2net cloud based platform to enable its mHealth blood glucose meter to reliably deliver data to integrated portals and databases designed to increase security and interoperability.
The Telcare BGM device won raves from Walt Mossberg, the Wall Street Journal‘s tech guru in early 2012. Later last year the company locked down a $26 million funding round. Telcare’s BGM won 510(k) clearance from the FDA in August 2011.
